Customization: | Available |
---|---|
Powder: | Yes |
Customized: | Non-Customized |
Still deciding? Get samples of US$ 25/kg
Request Sample
|
Suppliers with verified business licenses
Audited by an independent third-party inspection agency
Product Description:
Linezolid
Linezolid is a synthetic antibiotic belonging to the oxazolidinone class. It is primarily used to treat infections caused by Gram-positive bacteria, including those that are resistant to other antibiotics. Linezolid is available in oral and intravenous formulations, making it versatile for both outpatient and inpatient settings. Our Linezolid products are manufactured under stringent pharmaceutical standards to ensure purity, safety, and efficacy. This antibiotic is particularly valuable in the treatment of infections that are resistant to multiple drugs, offering a reliable option for severe and complicated cases.
Function:
Bacteriostatic Action: Linezolid works by inhibiting bacterial protein synthesis. It binds to the bacterial ribosome, preventing the initiation of protein synthesis, which is essential for bacterial growth and replication. This action is primarily bacteriostatic but can be bactericidal against certain strains of bacteria.
Effective Against Resistant Bacteria: Linezolid is particularly effective against Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococci (VRE), and penicillin-resistant Streptococcus pneumoniae. This makes it a crucial option in the treatment of resistant infections.
High Oral Bioavailability: The oral formulation of Linezolid has high bioavailability, similar to the intravenous form, allowing for effective treatment in outpatient settings and simplifying the switch from intravenous to oral therapy.
Dual Forms of Administration: Linezolid is available in both oral and intravenous forms, providing flexibility in administration and ensuring continuous treatment in both hospital and outpatient settings.
Excellent Tissue Penetration: Linezolid penetrates well into various body tissues and fluids, including the lungs, making it effective in treating respiratory tract infections.
Application:
Skin and Soft Tissue Infections: Linezolid is commonly used to treat complicated skin and soft tissue infections caused by Gram-positive bacteria, including those resistant to other antibiotics.
Pneumonia: It is effective in treating both hospital-acquired and community-acquired pneumonia caused by susceptible Gram-positive bacteria, including MRSA.
Bloodstream Infections: Linezolid is used in the treatment of bacteremia and sepsis caused by Gram-positive organisms, especially when other treatments are not effective due to resistance.
Bone and Joint Infections: It is also used in the management of bone and joint infections, such as osteomyelitis, particularly when these are caused by resistant Gram-positive bacteria.
Central Nervous System Infections: Due to its good tissue penetration, Linezolid can be used in treating infections of the central nervous system, such as meningitis, especially when caused by resistant organisms.
Multidrug-Resistant Infections: Linezolid is a key antibiotic in treating infections caused by multidrug-resistant bacteria, offering a vital option for infections that do not respond to standard therapies.
Outpatient and Inpatient Use: The availability of both oral and intravenous formulations allows for flexible dosing and the possibility of transitioning from inpatient to outpatient care, which can reduce hospital stay and healthcare costs.
Limited Use for Preventing Resistance: Due to the potential for developing resistance, Linezolid is generally reserved for specific, confirmed infections and is not typically used as a first-line treatment unless necessary.